Miriam Dervan, founder & CEO of mdgroup, explains how treating patient experience as a strategic investment—rather than a secondary consideration—changes how sponsors, sites, and operational teams design and deliver clinical trials.
Miriam Dervan
Advertisement
Founder & CEO, mdgroup
Articles by Miriam Dervan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Keynote Fireside Chat: Aligning Purpose, Innovation, and Operational Excellence in Clinical Development
2
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
3
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
4
SCOPE Summit 2026: Why Site Selectivity Is Beginning to Reshape Sponsor Relationships
5